RAS inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAS inhibitors, covering 2025-03-14 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab and RASi in Patients with IgAN [Phase 4]